A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: Part 1: Definitions, conservative management and contrast-induced nephropathy

Nephrology Dialysis Transplantation

Volumn 27, Issue 12, 2012, Pages 4263-4272

  Fliser, Danilo ^a   Laville, Maurice ^b   Covic, Adrian ^c   Fouque, Denis ^b   Vanholder, Raymond ^d   Juillard, Laurent ^b   Van Biesen, Wim ^d  

^a SAARLAND UNIVERSITY   (Germany)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

acute kidney injury; contrast induced nephropathy; diagnosis; guideline; prevention

Indexed keywords

ACETYLCYSTEINE; ACICLOVIR; ADRENALIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; ANIDULAFUNGIN; ATRIAL NATRIURETIC FACTOR; CASPOFUNGIN; CONTRAST MEDIUM; CREATININE; DIURETIC AGENT; DOPAMINE; FENOLDOPAM; FLUCONAZOLE; FOSCARNET; FUROSEMIDE; INSULIN; ITRACONAZOLE; MICAFUNGIN; NESIRITIDE; NORADRENALIN; PLACEBO; POSACONAZOLE; THEOPHYLLINE; URODILATIN; VASOPRESSIN; VORICONAZOLE;

ACUTE KIDNEY FAILURE; BLOOD TOXICITY; CONSERVATIVE TREATMENT; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG COST; DRUG DOSE COMPARISON; DRUG INDICATION; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; ENDOCARDITIS; FLUID THERAPY; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HEART ARRHYTHMIA; HEMODIALYSIS; HEMODYNAMIC MONITORING; HEMOFILTRATION; HUMAN; HYPERGLYCEMIA; HYPERVOLEMIA; HYPOGLYCEMIA; HYPOTENSION; LIVER TOXICITY; LOW DRUG DOSE; NEPHROTOXICITY; NUTRITIONAL SUPPORT; OLIGURIA; OTOTOXICITY; PARENTERAL NUTRITION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; PROTEINURIA; RECOMMENDED DRUG DOSE; REPEATED DRUG DOSE; REVIEW; RISK ASSESSMENT; SINGLE DRUG DOSE; URINE VOLUME;

ACUTE KIDNEY INJURY; CONTRAST MEDIA; HUMANS; KIDNEY DISEASES; TERMINOLOGY AS TOPIC;

EID: 84870329909     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs375     Document Type: Review

References (77)

1. Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 2012; 81: 442-448
2. Bucaloiu ID, Kirchner HL, Norfolk ER et al. Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. Kidney Int 2012; 81: 477-485
3. Chawla LS, Amdur RL, Amodeo S et al. The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int 2011; 79: 1361-1369
4. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney inter 2012; 2(Suppl): 1-138
5. Zoccali C, Abramowicz D, Cannata-Andia JB et al. European best practice quo vadis? From European Best Practice Guidelines (EBPG) to European Renal Best Practice (ERBP). Nephrol Dial Transplant 2008; 23: 2162-2166
6. ERBP. ERBP instructions to authors. www.european-renal-bestpractice. org. Accessed 2 October 2012.
7. Bellomo R, Ronco C, Kellum JA et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-R212
8. Mehta RL, Kellum JA, Shah SVet al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31
9. Van Biesen W, Van Massenhove J, Hoste E et al. Defining acute kidney injury: playing hide-and-seek with the unknown man? Nephrol Dial Transplant 2011; 26: 399-401
10. Bagshaw SM, George C, Dinu I et al. A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008; 23: 1203-1210
11. Ishani A, Nelson D, Clothier B et al. The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death. Arch Intern Med 2011; 171: 226-233
12. Bagshaw SM, George C, Bellomo R. A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008; 23: 1569-1574
13. Hoste EA, Clermont G, Kersten A et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 2006; 10: R73
14. MacLeod A. NCEPOD report on acute kidney injury-must do better. Lancet 2009; 374: 1405-1406
15. Siew ED, Matheny ME, Ikizler TA et al. Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury. Kidney Int 2010; 77: 536-542
16. Candela-Toha AM, Recio-Vazquez M, Delgado-Montero A et al. The calculation of baseline serum creatinine overestimates the diagnosis of acute kidney injury in patients undergoing cardiac surgery. Nefrologia 2012; 32: 53-58
17. Pickering JW, Endre ZH. Back-calculating baseline creatinine with MDRD misclassifies acute kidney injury in the intensive care unit. Clin J Am Soc Nephrol 2010; 5: 1165-1173
18. Zavada J, Hoste E, Cartin-Ceba R et al. A comparison of three methods to estimate baseline creatinine for RIFLE classification. Nephrol Dial Transplant 2010; 25: 3911-3918
19. Claure-Del Granado R, Macedo E, Chertow GM et al. Toward the optimal dose metric in continuous renal replacement therapy. Int J Artif Organs 2012; 35: 413-424
20. Macedo E, Malhotra R, Claure-Del Granado R et al. Defining urine output criterion for acute kidney injury in critically ill patients. Nephrol Dial Transplant 2011; 26: 509-515
21. Haase M, Devarajan P, Haase-Fielitz A et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol 2011; 57: 1752-1761
22. Lameire NH, Vanholder RC, Van Biesen WA. How to use biomarkers efficiently in acute kidney injury. Kidney Int 2011; 79: 1047-1050
23. Lafrance JP, Djurdjev O, Levin A. Incidence and outcomes of acute kidney injury in a referred chronic kidney disease cohort. Nephrol Dial Transplant 2010; 25: 2203-2209
24. James MT, Hemmelgarn BR, Wiebe N et al. Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study. Lancet 2010; 376: 2096-2103
25. Lin YF, Wu VC, Ko WJ et al. Residual urine output and postoperative mortality in maintenance hemodialysis patients. Am J Crit Care 2009; 18: 446-455
26. Grams ME, Estrella MM, Coresh J et al. Fluid balance, diuretic use, and mortality in acute kidney injury. Clin J Am Soc Nephrol 2011; 6: 966-973
27. Rivers E, Nguyen B, Havstad S et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-1377
28. Brunkhorst FM, Engel C, Bloos F et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125-139
29. Bunn F, Trivedi D, Ashraf S. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev 2008; CD001319
30. Martin C, Viviand X, Leone M et al. Effect of norepinephrine on the outcome of septic shock. Crit Care Med 2000; 28: 2758-2765
31. Kellum JA, Decker JM. Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 2001; 29: 1526-1531
32. Friedrich JO, Adhikari N, Herridge MS et al.Meta-analysis: lowdose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 2005; 142: 510-524
33. Brienza N, Giglio MT, Marucci M et al.Does perioperative hemodynamic optimization protect renal function in surgical patients? A meta-analytic study. Crit Care Med 2009; 37: 2079-2090
34. Boldt J. Clinical review: hemodynamic monitoring in the intensive care unit. Crit Care 2002; 6: 52-59
35. van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359-1367
36. Finfer S, Chittock DR, Su SY et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-1297
37. Griesdale DE, de Souza RJ, van Dam RM et al. Intensive insulin therapy and mortality among critically ill patients: a metaanalysis including NICE-SUGAR study data. CMAJ 2009; 180: 821-827
38. Marik PE, Preiser JC. Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis. Chest 2010; 137: 544-551
39. Gramlich L, Kichian K, Pinilla J et al. Does enteral nutrition compared to parenteral nutrition result in better outcomes in critically ill adult patients? A systematic review of the literature. Nutrition 2004; 20: 843-848
40. Cangelosi MJ, Auerbach HR, Cohen JT. A clinical and economic evaluation of enteral nutrition. Curr Med Res Opin 2011; 27: 413-422
41. Cove ME, Pinsky MR. Early or late parenteral nutrition: ASPEN vs. ESPEN. Crit Care 2011; 15: 317
42. Mehta RL, Pascual MT, Soroko S et al. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA 2002; 288: 2547-2553
43. Ho KM, Sheridan DJ. Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ 2006; 333: 420
44. Sampath S, Moran JL, Graham PL et al. The efficacy of loop diuretics in acute renal failure: assessment using Bayesian evidence synthesis techniques. Crit Care Med 2007; 35: 2516-2524
45. Landoni G, Biondi-Zoccai GG, Marino G et al. Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis. J Cardiothorac Vasc Anesth 2008; 22: 27-33
46. Girois SB, Chapuis F, Decullier E et al. Adverse effects of antifungal therapies in invasive fungal infections: review and meta-analysis. Eur J Clin Microbiol Infect Dis 2005; 24: 119-130
47. Johansen HK, Gotzsche PC. Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients. Cochrane Database Syst Rev 2002; CD000239
48. Schweiger MJ, Chambers CE, Davidson CJ et al. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures. Catheter Cardiovasc Interv 2007; 69: 135-140
49. Stacul F, van der Molen AJ, Reimer P et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 2011; 21: 2527-2541
50. Bruce RJ, Djamali A, Shinki K et al. Background fluctuation of kidney function versus contrast-induced nephrotoxicity. AJR Am J Roentgenol 2009; 192: 711-718
51. Davidson CJ, Hlatky M, Morris KG et al. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial. Ann Intern Med 1989; 110: 119-124
52. Detrenis S, Meschi M, del Mar Jordana Sanchez M et al. Contrast medium induced nephropathy in urological practice. J Urol 2007; 178: 1164-1170
53. Hardiek KJ, Katholi RE, Robbs RS et al. Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography. J Diabetes Complications 2008; 22: 171-177
54. Reddan D, Laville M, Garovic VD. Contrast-induced nephropathy and its prevention: What do we really know from evidence-based findings? J Nephrol 2009; 22: 333-351
55. Rudnick MR, Goldfarb S, Wexler L et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 1995; 47: 254-261
56. Solomon RJ, Natarajan MK, Doucet S et al. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized doubleblind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation 2007; 115: 3189-3196
57. Ribichini F, Graziani M, Gambaro G et al. Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. Am J Med 2010; 123: 755-763
58. Lameire N, Adam A, Becker CR et al. Baseline renal function screening. Am J Cardiol 2006; 98: 21K-26K
59. Stratta P, Bozzola C, Quaglia M. Pitfall in nephrology: contrast nephropathy has to be differentiated from renal damage due to atheroembolic disease. J Nephrol 2012; 25: 282-289
60. Karlsberg RP, Dohad SY, Sheng R. Contrast medium-induced acute kidney injury: comparison of intravenous and intraarterial administration of iodinated contrast medium. J Vasc Interv Radiol 2011; 22: 1159-1165
61. Chou SH, Wang ZJ, Kuo J et al. Persistent renal enhancement after intra-arterial versus intravenous iodixanol administration. Eur J Radiol 2011; 80: 378-386
62. Mockel M, Radovic M, Kuhnle Y et al. Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography. Nephrol Dial Transplant 2008; 23: 1588-1594
63. Lameire NH. Contrast-induced nephropathy-prevention and risk reduction. Nephrol Dial Transplant 2006; 21: i11-i23
64. Gupta RK, Kapoor A, Tewari S et al. Captopril for prevention of contrast-induced nephropathy in diabetic patients: a randomised study. Indian Heart J 1999; 51: 521-526
65. Shemirani H, Pourrmoghaddas M. A randomized trial of saline hydration to prevent contrast-induced nephropathy in patients on regular captopril or furosemide therapy undergoing percutaneous coronary intervention. Saudi J Kidney Dis Transpl 2012; 23: 280-285
66. Taylor AJ, Hotchkiss D, Morse RWet al. PREPARED: Preparation for Angiography in Renal Dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction. Chest 1998; 114: 1570-1574
67. Trivedi HS, Moore H, Nasr S et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 2003; 93: C29-C34
68. Yoshikawa D, Isobe S, Sato K et al. Importance of oral fluid intake after coronary computed tomography angiography: an observational study. Eur J Radiol 2011; 77: 118-122
69. Cho R, Javed N, Traub D et al. Oral hydration and alkalinization is noninferior to intravenous therapy for prevention of contrast-induced nephropathy in patients with chronic kidney disease. J Interv Cardiol 2010; 23: 460-466
70. Dussol B, Morange S, Loundoun A et al. A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients. Nephrol Dial Transplant 2006; 21: 2120-2126
71. Fishbane S. N-acetylcysteine in the prevention of contrast-induced nephropathy. Clin J Am Soc Nephrol 2008; 3: 281-287
72. Hoffmann U, Fischereder M, Kruger B et al. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 2004; 15: 407-410
73. Vogt B, Ferrari P, Schonholzer C et al. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 2001; 111: 692-698
74. Reinecke H, Fobker M, Wellmann J et al. A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the Dialysis-versus- Diuresis (DVD) Trial. Clin Res Cardiol 2007; 96: 130-139
75. Lee PT, Chou KJ, Liu CP et al. Renal protection for coronary angiography in advanced renal failure patients by prophylactic hemodialysis. A randomized controlled trial. J Am Coll Cardiol 2007; 50: 1015-1020
76. Marenzi G, Lauri G, Campodonico J et al. Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. Am J Med 2006; 119: 155-162
77. Marenzi G, Marana I, Lauri G et al. The prevention of radiocontrastagent-induced nephropathy by hemofiltration. N Engl J Med 2003; 349: 1333-1340